Ronne Yeo, PhD
Principal, Esco Ventures
Vice President, Discovery, Carmine Therapeutics
Ronne is a Senior Associate at Esco Ventures, where he explores innovative science and platform technologies to build biotech companies that would advance medicine and impact human health. He is a founding member of Carmine Therapeutics, a biotech startup developing extracellular vesicle-based therapeutics, with Professors Harvey Lodish, Minh Le and Jiahai Shi as scientific co-founders. Ronne also pioneered and leads the Morphosis Program, a Fellowship founded in 2018 with the aim to nurture bio-entrepreneurs and enhance the biotech startup ecosystem in Singapore.
Prior to joining Esco Ventures, Ronne was a Senior Research Fellow at A*STAR Institute of Medical Biology, where he was involved in the preclinical development of mesenchymal stem cell extracellular vesicles - a novel therapeutic modality. During his postdoctoral stint, he also co-invented an active ingredient for skin barrier restoration that led to a spin-off company. Ronne obtained his PhD from NUS Graduate School for Integrative Sciences and Engineering (NGS), and a BSc in Biological Sciences from Nanyang Technological University.